secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2023-07-18T23:59:59+00:00
Accession:  0001493152-23-024835
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TenX Keane extends business combination deadline to Oct 18, 2023 with $660k deposit
--------------------------------------------------------------------------------

- Deposited $660k ($0.10 per public share) into trust to extend business combination deadline.
- Deadline extended from July 18, 2023 to October 18, 2023.
- Sponsor 10XYZ Holdings LP provided funds via unsecured promissory note.
- Note convertible up to $1.5M into private units at $10/unit upon business combination.
- Extension is first of up to three possible 3-month extensions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000149315223024835/0001493152-23-024835-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000149315223024835/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024835

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer